Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, and CardioFocus, Inc., a medical device company dedicated to advancing ...
An Abbott (NYSE: ABT) official posted on social media to announce FDA breakthrough device designation for a new ablation ...
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no longer be controlled with medication.
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no longer be controlled with medication.
The Food and Drug Administration has published an early alert about risks posed by Abbott’s Tactiflex Ablation Catheter. Officials published the alert Thursday in response to Abbott writing to ...
A newly published study in prestigious electrophysiology journal, HeartRhythm, reveals same-day discharge after catheter pulsed-field ablation (PFA) for atrial fibrillation (AFib) patients may improve ...
Piedmont Cartersville (Ga.), part of Atlanta-based Piedmont Healthcare, in partnership with Cumming, Ga.-based Heart and Vascular Care, successfully completed the first cardiac ablation procedure in ...
Cardiology is rapidly shifting to the outpatient setting, with CMS’ proposed 2026 payment rule adding more than 200 ASC-eligible procedures and paving the way for wider adoption of high-acuity cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback